An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3

Steroid hormones may enter cells by diffusion through the plasma membrane. However, we demonstrate here that some steroid hormones are taken up by receptor-mediated endocytosis of steroid-carrier complexes. We show that 25-(OH) vitamin D3 in complex with its plasma carrier, the vitamin D-binding protein, is filtered through the glomerulus and reabsorbed in the proximal tubules by the endocytic receptor megalin. Endocytosis is required to preserve 25-(OH) vitamin D3 and to deliver to the cells the precursor for generation of 1,25-(OH)2 vitamin D3, a regulator of the calcium metabolism. Megalin-/- mice are unable to retrieve the steroid from the glomerular filtrate and develop vitamin D deficiency and bone disease.

[1]  J. Bergeron,et al.  Mapping and conservation of the group-specific component gene in mouse. , 1990, Genomics.

[2]  S. Kato,et al.  25-Hydroxyvitamin D3 1α-Hydroxylase and Vitamin D Synthesis , 1997 .

[3]  M. Farquhar,et al.  Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D K Burns,et al.  Defective forebrain development in mice lacking gp330/megalin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Siiteri,et al.  3 Changing concepts of active androgens in blood , 1986 .

[6]  D. Phillips,et al.  Receptor-mediated endocytosis of an extracellular steroid-binding protein (TeBG) in MCF-7 human breast cancer cells. , 1991, Endocrinology.

[7]  P. Siiteri,et al.  Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. , 1985, The Journal of clinical endocrinology and metabolism.

[8]  J. Henkin,et al.  gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. , 1995, Journal of cell science.

[9]  H. Harrison.  The Fanconi syndrome. , 1958, Journal of chronic diseases.

[10]  J. Haddad.  Plasma vitamin D-binding protein (Gc-globulin): Multiple tasks , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  A. Evan,et al.  In vitro regulation of kidney 25-hydroxyvitamin D3-hydroxylase enzyme activities by vitamin D3 metabolites. Molecular specificity and mechanism of action. , 1980, The Journal of biological chemistry.

[12]  T. Hammond,et al.  Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. , 1995, European journal of cell biology.

[13]  J. Cidlowski,et al.  Regulation of apoptosis by steroid hormones , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  R. Prince,et al.  Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. , 1992, Nephron.

[15]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[16]  C. Porto,et al.  Receptors for androgen-binding proteins: Internalization and intracellular signalling , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  D. Lawson,et al.  Vitamin D plasma binding protein. Turnover and fate in the rabbit. , 1981, The Journal of clinical investigation.

[18]  R. Holmes,et al.  The uptake and metabolism of 25-hydroxyvitamin D3 and vitamin D binding protein by cultured porcine kidney cells (LLC-PK1). , 1991, The International journal of biochemistry.

[19]  C. Mendel.  The free hormone hypothesis: a physiologically based mathematical model. , 1989, Endocrine reviews.

[20]  A. Matus,et al.  The Low Density Lipoprotein Receptor Gene Family , 1998, The Journal of Biological Chemistry.

[21]  J. Haddad,et al.  Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. , 1986, The Journal of clinical endocrinology and metabolism.

[22]  Aoshima Keiko,et al.  Demonstration of vitamin D-binding protein (Gc-globulin) in the urine of Itai-itai disease patients. , 1983 .

[23]  R. W. Kuhn,et al.  The serum transport of steroid hormones. , 1982, Recent progress in hormone research.

[24]  S. Moestrup,et al.  Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Moestrup,et al.  beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. , 1998, The Journal of clinical investigation.

[26]  S. Moestrup,et al.  Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. , 1995, The Journal of clinical investigation.